Graf Akcie VNDA (Vanda Pharmaceuticals Inc). Diskuze k akciím VNDA. Aktuální informace VNDA.

Základní informace o společnosti Vanda Pharmaceuticals Inc (Akcie VNDA)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 1.01B
Hodnota podniku (EV) 522.65M
Tržby 258.529M
EBITDA 42.381M
Zisk 32.44M
Růst v tržbách Q/Q 9.15 %
Růst v tržbách Y/Y 7.44 %
P/E (Cena vůči ziskům) 31.08
Forward P/E 0.50
EV/Sales 2.02
EV/EBITDA 12.33
EV/EBIT 12.34
PEG 2.07
Price/Sales 3.90
P/FCF 18.24
Price/Book 2.22
Účetní hodnota na akcii 8.25
Hotovost na akcii 6.69
FCF vůči ceně 5.48 %
Počet zaměstnanců 292
Tržba na zaměstnance 885.373k
Profit margin 9.40 %
Operating margin 15.82 %
Gross margin 90.59 %
EBIT margin 16.38 %
EBITDA margin 16.39 %
EPS - Zisk na akcii 0.59
EPS - Kvartální růst 6.25 %
EPS - Očekávaný růst příští rok 45.45 %
Return on assets 6.01 %
Return on equity 7.04 %
ROIC 6.22 %
ROCE 8.55 %
Dluhy/Equity 0.18
Čistý dluh/EBITDA -34.12
Current ratio 6.20
Quick Ratio 6.08
Volatilita 3.01
Beta 1.14
RSI 65.41
Cílová cena analytiků 18
Známka akcie (dle analytiků) 1.00
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 55.638M
Procento shortovaných akcií 11.22 %
Short ratio 13.64 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2006
Země United States

Finanční výsledky akcie VNDA

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$248.168$227.188$193.118$165.083$146.017$109.925
Cost Of Goods Sold$23.364$24.488$20.508$17.848$24.712$23.462
Gross Profit$224.804$202.7$172.61$147.235$121.305$86.463
Research And Development Expenses$55.577$48.649$43.594$38.547$29.156$29.145
SG&A Expenses$140.51$129.736$105.751$123.841$99.787$84.531
Other Operating Income Or Expenses------
Operating Expenses$220.929$204.378$171.38$181.986$164.588$150.11
Operating Income$27.239$22.81$21.738$-16.903$-18.571$-40.185
Total Non-Operating Income/Expense$4.416$6.218$3.608$1.472$0.665$0.32
Pre-Tax Income$31.655$29.028$25.346$-15.431$-17.906$-39.865
Income Taxes$8.318$-86.525$0.138$0.136$0.104-
Income After Taxes$23.337$115.553$25.208$-15.567$-18.01$-39.865
Other Income------
Income From Continuous Operations$23.337$115.553$25.208$-15.567$-18.01$-39.865
Income From Discontinued Operations------
Net Income$23.337$115.553$25.208$-15.567$-18.01$-39.865
EBITDA$30.282$22.603$22.473$-14.345$-6.703$-25.954
EBIT$27.239$22.81$21.738$-16.903$-18.571$-40.185
Basic Shares Outstanding545351454342
Shares Outstanding555553454342
Basic EPS$0.43$2.17$0.50$-0.35$-0.41$-0.94
EPS - Earnings Per Share$0.42$2.11$0.48$-0.35$-0.41$-0.94
# 2020 2019 2018 2017 2016 2015
Current Ratio6.20525.95145.64242.4143.46133.2455
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin90.585489.221389.380689.188583.075978.6564
Operating Margin10.97610.040211.2563-10.2391-12.7184-36.5567
EBIT Margin10.97610.040211.2563-10.2391-12.7184-36.5567
EBITDA Margin12.20229.94911.6369-8.6896-4.5906-23.6106
Pre-Tax Profit Margin12.755512.777113.1246-9.3474-12.263-36.2656
Net Profit Margin9.403750.862313.0532-9.4298-12.3342-36.2656
Asset Turnover0.46520.46960.58150.80360.69410.516
Inventory Turnover Ratio18.253121.480720.631821.247631.722718.1314
Receiveable Turnover8.26248.61646.71019.37927.20436.7311
Days Sales In Receivables44.176342.361254.395238.91650.664154.2262
ROE - Return On Equity5.148628.11889.1525-11.8482-13.7136-29.9676
Return On Tangible Equity5.405829.788810.0478-14.781-17.3991-42.2859
ROA - Return On Assets4.374723.8877.5898-7.5779-8.5609-18.7116
ROI - Return On Investment5.148628.11899.1525-11.8482-13.7136-29.9676
Book Value Per Share8.26157.6745.24832.92372.98473.107
Operating Cash Flow Per Share0.10040.27240.60960.1422-0.48122.5177
Free Cash Flow Per Share0.08640.26080.63990.1374-0.45372.4787